CJC-1295 (no DAC) is a synthetic analog of growth-hormone-releasing hormone (GHRH). Unlike the DAC-modified version, it lacks the Drug Affinity Complex that binds serum albumin to extend half-life — its research duration profile sits closer to native GHRH and to Sermorelin than to long-acting GHRH analogs.
Mechanism, common research protocols, evidence review, and cited primary literature for CJC-1295 (no DAC) live on the full guide.